These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33905671)

  • 1. NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation.
    Zhao X; Jiang L; Hu D; Tang Y; Zhao G; Du X; Luo S; Tang W
    Exp Cell Res; 2021 Jun; 403(2):112614. PubMed ID: 33905671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
    Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
    Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
    Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting NPRL2 to enhance the efficacy of Olaparib in castration-resistant prostate cancer.
    Chen X; Chen Z; Zheng B; Tang W
    Biochem Biophys Res Commun; 2019 Jan; 508(2):620-625. PubMed ID: 30522863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
    Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
    Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Nedd8‑conjugating enzyme UBE2M suppresses the proliferation and induces the apoptosis of intrahepatic cholangiocarcinoma cells.
    Zhao B; Gao C; Shi D; Mao J; Zhao J; Guo L; Guo J; Jiao Z
    Oncol Rep; 2019 Dec; 42(6):2670-2679. PubMed ID: 31545502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
    Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
    Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.
    Zhou W; Xu J; Tan M; Li H; Li H; Wei W; Sun Y
    Mol Cell; 2018 Jun; 70(6):1008-1024.e6. PubMed ID: 29932898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
    Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
    Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
    Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
    Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy.
    Zheng B; Qian F; Wang X; Wang Y; Zhou B; Fang L
    J Exp Clin Cancer Res; 2024 Jun; 43(1):177. PubMed ID: 38926803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
    Zhou H; Lu J; Yang CY; Sun Y; Wang S
    Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting neddylation E2s: a novel therapeutic strategy in cancer.
    Zheng YC; Guo YJ; Wang B; Wang C; Mamun MAA; Gao Y; Liu HM
    J Hematol Oncol; 2021 Apr; 14(1):57. PubMed ID: 33827629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
    Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
    Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
    [No Abstract]   [Full Text] [Related]  

  • 17. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways.
    Zhang D; Liu H; Yang B; Hu J; Cheng Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.
    Liao Y; Liu Y; Xia X; Shao Z; Huang C; He J; Jiang L; Tang D; Liu J; Huang H
    Theranostics; 2020; 10(8):3366-3381. PubMed ID: 32206096
    [No Abstract]   [Full Text] [Related]  

  • 20. Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.
    Liu S; Liu B
    Med Sci Monit; 2018 Mar; 24():1424-1433. PubMed ID: 29519997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.